271 related articles for article (PubMed ID: 16715110)
1. Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?
Bahlis NJ; Lazarus HM
Bone Marrow Transplant; 2006 Jul; 38(1):7-15. PubMed ID: 16715110
[TBL] [Abstract][Full Text] [Related]
2. Primary (AL) amyloidosis in plasma cell disorders.
Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
[TBL] [Abstract][Full Text] [Related]
3. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
[TBL] [Abstract][Full Text] [Related]
4. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
[TBL] [Abstract][Full Text] [Related]
5. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
Hayes-Lattin BM; Curtin PT; Fleming WH; Leis JF; Stepan DE; Schubach S; Maziarz RT
Bone Marrow Transplant; 2002 Sep; 30(5):279-85. PubMed ID: 12209349
[TBL] [Abstract][Full Text] [Related]
6. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
Bird JM; Fuge R; Sirohi B; Apperley JF; Hunter A; Snowden J; Mahendra P; Milligan D; Byrne J; Littlewood T; Fegan C; McQuaker G; Pagliuca A; Johnson P; Rahemtulla A; Morris C; Marks DI;
Br J Haematol; 2006 Aug; 134(4):385-90. PubMed ID: 16822294
[TBL] [Abstract][Full Text] [Related]
7. Transplantation for amyloidosis.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
[TBL] [Abstract][Full Text] [Related]
8. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
10. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
11. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
13. Amyloidosis in multiple myeloma or without apparent cause.
Alexanian R; Fraschini G; Smith L
Arch Intern Med; 1984 Nov; 144(11):2158-60. PubMed ID: 6437354
[TBL] [Abstract][Full Text] [Related]
14. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
15. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
Graziani MS; Merlini G
Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
[TBL] [Abstract][Full Text] [Related]
16. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment in systemic amyloidosis].
Ikeda S
Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826
[TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma in end-stage renal disease.
Penfield JG
Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.
Gertz MA
Am J Hematol; 2011 Feb; 86(2):180-6. PubMed ID: 21264900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
